# US Cardiopulmonary Exercise Testing Market > US Cardiopulmonary Exercise Testing Market Research Report By Product (CPET Metabolic Carts, Software) and By End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Centers, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.38% - **2024:** $ 235.2 Million - **2025:** $ 254.91 Million - **2035:** $ 570 Million - **Key Players:** Cardinal Health (US), Philips (NL), GE Healthcare (US), Schiller AG (CH), MediSoft (FR), Cosmed (IT), KORR Medical Technologies (US), Bodystat (GB) **Report ID:** MRFR/HC/51273-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-cardiopulmonary-exercise-testing-market-53034 --- ## Market Summary ## **US Cardiopulmonary Exercise Testing Market Overview** As per MRFR analysis, the US Cardiopulmonary Exercise Testing Market Size was estimated at 220.5 (USD Million) in 2023.The US Cardiopulmonary Exercise Testing Market Industry is expected to grow from 235.2(USD Million) in 2024 to 530 (USD Million) by 2035. The US Cardiopulmonary Exercise Testing Market CAGR (growth rate) is expected to be around 7.665% during the forecast period (2025 - 2035) ## **Key US Cardiopulmonary Exercise Testing Market Trends Highlighted** The US Cardiopulmonary Exercise Testing Market is experiencing notable market trends driven by an increasing awareness of the importance of cardiovascular health and the rising prevalence of chronic diseases. Cardiopulmonary exercise testing (CPET) is becoming essential in the diagnosis and management of conditions such as heart failure, chronic obstructive pulmonary disease, and other respiratory diseases. This growing recognition of CPET's role in clinical practice is prompting healthcare providers to adopt these tests more widely. Additionally, advancements in technology are allowing for more accurate and efficient testing procedures, making CPET more accessible to a broad range of patients. Opportunities to be explored include the integration of telemedicine and remote monitoring with CPET. As telehealth continues to grow in the US, healthcare facilities can enhance patient engagement and streamline the testing process, leading to better patient outcomes. Furthermore, there is potential for the introduction of new devices and protocols specifically designed for at-home testing, making CPET available to patients who may have difficulty accessing traditional healthcare settings. Trends in recent times indicate an increase in research conducted on the role of exercise testing in various therapeutic and rehabilitation settings. Emphasis is being placed on developing personalized medicine approaches that tailor exercise prescriptions based on individual patient profiles. This focus aligns with the US healthcare system's shift towards value-based care, where outcomes are prioritized over the volume of services provided. With the growing emphasis on preventive care, facilities offering cardiopulmonary exercise testing may find themselves in a favorable position as healthcare systems seek to detect health issues early and improve overall population health. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Cardiopulmonary Exercise Testing Market Drivers** ### **Rising Prevalence of Respiratory and Cardiovascular Diseases** The rising prevalence of respiratory and cardiovascular disorders in the United States is accelerating the expansion of the US Cardiopulmonary Exercise Testing Market Industry. According to the Centers for Disease Control and Prevention (CDC), cardiovascular illnesses cause roughly 697,000 fatalities in the United States each year, accounting for one out of every five deaths. Chronic respiratory disorders are also on the rise, with the American Lung Association noting an increase in ailments, including chronic obstructive pulmonary disease (COPD) and asthma, which impact millions of people. This increase in disease incidence needs more thorough cardiac evaluations and exercise testing in clinical settings, creating a greater demand for improved cardiopulmonary testing procedures. National healthcare agencies, such as the National Heart, Lung, and Blood Institute, push for routine cardiovascular preventive testing, persuading hospitals to include these tests for improved patient outcomes. ### **Technological Advancements in Exercise Testing Equipment** Technological innovations within the US Cardiopulmonary Exercise Testing Market Industry are enhancing the accuracy and efficiency of testing procedures. Equipment providers are increasingly integrating sophisticated data analytics, real-time monitoring systems, and artificial intelligence functionalities into exercise testing systems. FDA approvals for newer, more advanced devices, such as portable spirometers and updated metabolic carts, are becoming more common. As per the FDA database, over 25 new technologies related to pulmonary and cardiovascular testing devices have been cleared since 2020 alone. This wave of innovation not only improves the testing experience but also promotes the broad adoption of exercise testing both in clinical and home settings. ### **Growing Awareness of Preventive Healthcare** The increased focus on preventive healthcare is translating into a greater demand for cardiopulmonary exercise testing in the United States. The US government and various health organizations are emphasizing the importance of preventive measures, which can significantly decrease healthcare costs associated with advanced diseases. According to the Office of Disease Prevention and Health Promotion, health promotion and preventive services help save approximately $2.10 for every dollar spent. As more healthcare providers aim to adopt preventive testing modalities, the US Cardiopulmonary Exercise Testing Market Industry stands poised for growth, particularly as fitness and wellness trends encourage individuals to participate in regular health assessments with a focus on cardiovascular health. ## **US Cardiopulmonary Exercise Testing Market Segment Insights** ### **Cardiopulmonary Exercise Testing Market Product Insights  ** The Product segment of the US Cardiopulmonary Exercise Testing Market is intricate and diverse, showcasing various technologies and solutions that cater to the growing demand for effective cardiopulmonary diagnostics and monitoring. Among these, CPET Metabolic Carts play a pivotal role as they are essential for comprehensive metabolic assessment during exercise testing. These carts provide critical insights into an individual’s cardiovascular and pulmonary efficiency, which is vital for both clinical and research purposes.  They enable healthcare professionals to assess responses to exercise, identify potential health issues, and develop tailored rehabilitation programs. The technological advancements in metabolic carts have fostered improved accuracy and user-friendliness, making them indispensable in cardiopulmonary evaluations across hospitals and fitness centers in the US. In addition to CPET Metabolic Carts, software solutions accompanying these devices have gained significant traction. This software not only enhances the functionality of the metabolic carts by processing and analyzing data efficiently but also allows for the integration of electronic health records, ensuring a seamless workflow for healthcare practitioners. The rise in telemedicine and remote patient monitoring has also led to an increased reliance on such software, as it aids in data sharing and management. With the growing emphasis on personalized medicine and preventative health measures, these software solutions enable tailored exercise prescriptions and ongoing patient engagement, thereby driving their importance in the industry. The US market is witnessing innovative developments in both hardware and software, which collectively enhance the quality of care provided to patients with cardiopulmonary conditions. As the focus on cardiovascular health continues to grow, the demand for advanced CPET Metabolic Carts and integrated software solutions is expected to expand, reflecting the overall trends within the US Cardiopulmonary Exercise Testing Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Cardiopulmonary Exercise Testing Market End User Insights  ** The US Cardiopulmonary Exercise Testing Market is significantly influenced by its End User segment, which comprises Hospitals and Clinics, Diagnostic Centers, Ambulatory Centers, and Others. Hospitals and Clinics play a crucial role in delivering essential cardiopulmonary tests, driving the demand due to their comprehensive care pathways and the presence of advanced medical technology. Diagnostic Centers are vital as they provide specialized services that cater to a wide array of patients seeking precise testing, thus contributing to the overall market dynamics. Ambulatory Centers are gaining prominence as they offer convenience and accessibility for patients, facilitating timely diagnosis and management of cardiopulmonary conditions. The Others category includes various healthcare facilities and flexible testing venues, which also contribute to the diversity of service options for patients. The trends in this segment reflect the increasing focus on preventive healthcare, pushing for enhanced testing capabilities across all types of facilities. As healthcare continues to evolve, the US Cardiopulmonary Exercise Testing Market segmentation reveals critical insights into healthcare delivery, highlighting the importance of diverse End Users in improving patient outcomes and accessibility. ## **US Cardiopulmonary Exercise Testing Market Key Players and Competitive Insights** The US Cardiopulmonary Exercise Testing Market is characterized by a range of competitive dynamics shaped by various factors, including technological advancements, regulatory frameworks, and a growing emphasis on preventive healthcare. The demand for cardiopulmonary exercise testing is propelled by the increasing prevalence of respiratory and cardiovascular diseases, along with the rising awareness about the importance of exercise testing in clinical settings. This environment has led to the emergence of several key players that are continually innovating to capture market share.Companies are engaging in strategic partnerships, mergers, and acquisitions to enhance their product offerings and improve their overall competitive positions. The landscape of this market is dynamic, driven by advancements in testing technologies and increasing applications in both clinical and sports performance settings. CareFusion, known for its significant contributions to the medical equipment industry, maintains a strong presence in the US Cardiopulmonary Exercise Testing Market. The company has established itself as a reliable provider of respiratory and monitoring equipment, essential for conducting effective cardiopulmonary assessments. CareFusion’s strength lies in its commitment to innovation and high-quality products that meet regulatory standards. By offering a range of advanced testing solutions, the company has managed to build a loyal customer base among healthcare providers. Their focus on integrating cutting-edge technology, which allows for enhanced monitoring and analysis, sets them apart from competitors. Additionally, CareFusion’s comprehensive training and support services further solidify its reputation in the market, enabling healthcare professionals to utilize their equipment efficiently and effectively. Cosmed has positioned itself as a prominent player in the US Cardiopulmonary Exercise Testing Market, leveraging its expertise in cardiopulmonary diagnostics to deliver high-performance products and services. The company specializes in advanced metabolic and cardiopulmonary testing systems, which are integral to evaluating patient health and physical performance. Cosmed's strong emphasis on research and development has resulted in a portfolio that includes state-of-the-art metabolic carts and pulmonary function testing equipment.Its presence in the US market is further enhanced by strategic partnerships and collaborations, facilitating innovation and expanding its market reach. Strengths such as a robust distribution network and responsive customer service have contributed to its competitive edge. In recent years, Cosmed's strategic mergers and acquisitions have enabled it to diversify its product offerings, solidifying its position as a leader in cardiopulmonary exercise testing solutions while responding to the evolving needs of healthcare professionals across the United States. ### **Key Companies in the US Cardiopulmonary Exercise Testing Market Include** - CareFusion - [**Cosmed**](https://www.cosmed.com/en/resources/science/95-cardio-pulmonary-exercise-test/) - CardioCommand - Nihon Kohden - Huntleigh - Cleveland Medical Devices - Borg Health - MediCardia - Parker Hannifin - KORR Medical Technologies - GE Healthcare - Bodystat - Schiller AG - Mediware ## **US Cardiopulmonary Exercise Testing Market Industry Developments** The US Cardiopulmonary Exercise Testing Market has seen significant developments recently, particularly with advancements in technology and regulatory approvals. Companies such as GE Healthcare and Nihon Kohden are focusing on enhancing their product offerings to provide accurate diagnostics through innovative testing solutions. In terms of market dynamics, the increasing prevalence of cardiovascular diseases is driving demand for cardiopulmonary exercise testing, leading to a rise in market valuations for companies like CareFusion and Cosmed, which reported growth due in part to expanding applications in clinical settings.  Notably, in June 2023, CardioCommand acquired MediCardia, a strategic move aimed at enhancing capabilities in cardiopulmonary diagnostics. Additionally, partnerships among firms like Huntleigh and Cleveland Medical Devices are emerging to leverage synergies and improve patient care. Over the last two years, significant investments in Research and Development have been noted, with Borg Health and KORR Medical Technologies making strides in tailored exercise testing solutions. The US market’s landscape is evolving rapidly with an emphasis on integrating advanced technology and focusing on patient-centered approaches, thus reflecting a robust growth trajectory for the industry. ## **Cardiopulmonary Exercise Testing Market Segmentation Insights** ### **Cardiopulmonary Exercise Testing Market Product Outlook** - CPET Metabolic Carts - Software ### **Cardiopulmonary Exercise Testing Market End User Outlook** - Hospitals & Clinics - Diagnostic Centers - Ambulatory Centers - Others ## Market Drivers ### Growing Geriatric Population The aging population in the US significantly drives the cardiopulmonary exercise-testing market. As individuals age, the risk of developing cardiovascular and pulmonary diseases increases, necessitating regular health assessments. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, leading to a substantial rise in the demand for healthcare services, including cardiopulmonary exercise testing. This demographic shift is likely to create a larger patient base requiring these tests for early diagnosis and management of age-related health issues. Consequently, the cardiopulmonary exercise-testing market is expected to experience growth as healthcare systems adapt to meet the needs of an older population. ### Advancements in Medical Technology Technological innovations in medical devices and testing methodologies are propelling the cardiopulmonary exercise-testing market forward. Recent developments in exercise testing equipment, such as portable and more accurate devices, have made it easier for healthcare providers to conduct tests in various settings, including outpatient clinics and home care. These advancements not only enhance the accuracy of test results but also improve patient comfort and accessibility. As technology continues to evolve, the cardiopulmonary exercise-testing market is likely to see increased adoption of these advanced tools, leading to more widespread use and improved patient outcomes. ### Increased Focus on Personalized Medicine The trend towards personalized medicine is significantly influencing the cardiopulmonary exercise-testing market. As healthcare shifts from a one-size-fits-all approach to more tailored treatments, the need for precise diagnostic tools becomes paramount. Cardiopulmonary exercise testing provides valuable insights into an individual's cardiovascular and pulmonary responses to exercise, enabling healthcare professionals to customize treatment plans based on specific patient needs. This shift is supported by advancements in data analytics and wearable technology, which allow for more accurate monitoring of patient health. The cardiopulmonary exercise-testing market is likely to expand as healthcare providers increasingly adopt these personalized approaches, enhancing patient care and improving clinical outcomes. ### Rising Health Awareness and Preventive Care There is a growing trend towards health awareness and preventive care among the US population, which is positively impacting the cardiopulmonary exercise-testing market. Individuals are becoming more proactive about their health, seeking regular check-ups and screenings to prevent potential health issues. This shift is reflected in the increasing number of health and wellness programs offered by employers and healthcare organizations. As more people recognize the importance of cardiovascular health, the demand for cardiopulmonary exercise testing is expected to rise. This trend indicates a potential for market growth as healthcare providers respond to the increasing need for preventive health measures. ### Rising Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases in the US is a primary driver for the cardiopulmonary exercise-testing market. According to the American Heart Association, cardiovascular diseases account for approximately 697,000 deaths annually, representing about 1 in every 5 deaths. This alarming statistic underscores the necessity for effective diagnostic tools, such as cardiopulmonary exercise testing, which aids in assessing the functional capacity and overall health of patients. As healthcare providers seek to improve patient outcomes, the demand for these tests is likely to rise. Furthermore, the cardiopulmonary exercise-testing market is expected to benefit from the growing awareness among patients regarding the importance of early detection and management of cardiovascular conditions, potentially leading to increased testing rates and subsequent market growth. ## Future Outlook The [Cardiopulmonary Exercise Testing Market](https://www.marketresearchfuture.com/reports/cardiopulmonary-exercise-testing-market-6626) is projected to grow at a 8.38% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising health awareness. **New opportunities:** - Development of portable exercise testing devices for home use. Integration of AI analytics for personalized exercise prescriptions. Expansion of telehealth services for remote cardiopulmonary assessments. By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand. ## Segment Insights ### By Product Type: CPET metabolic carts (Largest) vs. software (Fastest-Growing) In the US cardiopulmonary exercise-testing market, CPET metabolic carts dominate the product type segment, reflecting a significant market share driven by their essential role in accurate assessment of cardiovascular and pulmonary functions. These devices are widely utilized in clinical settings, underscoring their importance in precise diagnosis and treatment planning for patients with respiratory and cardiac conditions. In contrast, software solutions are gradually gaining prominence, providing essential analytical capabilities that enhance the functionality of physical testing systems. The growth of the software segment is fueled by technological advancements and the increasing demand for digital health solutions. As healthcare shifts towards more integrated and data-driven practices, software supporting the analysis of test data is becoming a critical component of cardiopulmonary testing systems. Emerging trends such as telemedicine and remote monitoring are further driving the adoption of these software solutions, indicating a shift towards more comprehensive patient care and management strategies. CPET metabolic carts (Dominant) vs. software (Emerging) CPET metabolic carts are considered the dominant player in the product type segment due to their reliability and accuracy in conducting comprehensive metabolic assessments during exercise testing. These devices are equipped with advanced sensors and hardware, designed to precisely measure respiratory gases, heart rate, and other critical parameters. Their established presence in hospitals and rehabilitation centers accentuates their significance, supported by clinicians’ preference for proven technology. On the other hand, software solutions are emerging as a vital counterpart, offering analytics and reporting features that significantly enhance the capabilities of metabolic carts. As more healthcare providers recognize the importance of data in treatment decisions, the adoption of innovative software tools is increasing, thereby complementing traditional testing methods and enhancing overall patient outcomes. ### By End User: Hospitals & Clinics (Largest) vs. Diagnostic Centers (Fastest-Growing) In the US cardiopulmonary exercise-testing market, Hospitals & Clinics hold a significant share, serving as the primary venue for conducting comprehensive cardiopulmonary assessments. This segment benefits from the integration of advanced technologies and experienced healthcare professionals, allowing them to cater to a diverse patient population. Following closely, Diagnostic Centers are witnessing increased adoption, as they offer specialized services that meet the growing demand for timely and accurate testing, thus enhancing their market presence. Growth trends indicate that the Diagnostic Centers segment is rapidly expanding due to the rising prevalence of cardiovascular diseases and a greater emphasis on preventive healthcare measures. Innovations in testing technologies and a shift towards outpatient care are key drivers for this segment, as they enhance accessibility and convenience for patients. These trends are reshaping the landscape, positioning Diagnostic Centers as an integral part of the healthcare delivery system in the US. Hospitals & Clinics (Dominant) vs. Diagnostic Centers (Emerging) The Hospitals & Clinics segment remains dominant in the US cardiopulmonary exercise-testing market due to their extensive infrastructure and ability to provide a comprehensive range of cardiopulmonary assessments in one location. This segment is characterized by well-established protocols and a higher volume of procedures performed. On the other hand, Diagnostic Centers are emerging as a competitive force, offering specialized testing in a more patient-friendly environment. With advancements in technology and techniques, they provide quick turnaround times and precision in diagnostics. As more patients seek preventive care, these centers are increasingly seen as a convenient alternative, thus driving their growth and expanding their market share. ## Competitive Benchmarking The cardiopulmonary exercise-testing market has a dynamic competitive landscape. This landscape is driven by technological advancements and an increasing emphasis on personalized healthcare. Key players such as Cardinal Health (US), Philips (NL), and GE Healthcare (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Cardinal Health (US) focuses on expanding its product portfolio through strategic partnerships and acquisitions, while Philips (NL) emphasizes innovation in digital health solutions, aiming to integrate advanced analytics into their exercise-testing equipment. GE Healthcare (US) appears to be concentrating on enhancing operational efficiencies and expanding its global footprint, particularly in emerging markets, thereby shaping a competitive environment that is increasingly collaborative yet fiercely competitive. In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain resilience. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This collective presence of key players fosters a competitive atmosphere where innovation and customer-centric solutions are paramount, driving the market forward. In October 2025, Philips (NL) announced the launch of a new AI-driven cardiopulmonary exercise-testing system designed to enhance diagnostic accuracy and patient outcomes. This strategic move underscores Philips' commitment to integrating cutting-edge technology into its offerings, potentially setting a new standard in the industry. The introduction of AI capabilities may not only improve the efficiency of testing but also provide healthcare professionals with deeper insights into patient health, thereby reinforcing Philips' competitive edge. In September 2025, GE Healthcare (US) unveiled a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its cardiopulmonary exercise-testing solutions. This collaboration is indicative of a broader trend towards digital health integration, allowing for real-time data analysis and improved patient engagement. By leveraging telehealth, GE Healthcare (US) is likely to enhance its service delivery model, positioning itself as a leader in the evolving landscape of remote patient monitoring. In August 2025, Cardinal Health (US) completed the acquisition of a smaller firm specializing in innovative exercise-testing technologies. This acquisition is expected to bolster Cardinal Health's product offerings and enhance its competitive positioning in the market. By integrating these advanced technologies, Cardinal Health (US) may improve its operational capabilities and expand its reach within the healthcare sector, thereby solidifying its market presence. As of November 2025, the cardiopulmonary exercise-testing market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. The shift from price-based competition to a focus on innovation and technology is evident, as firms strive to differentiate themselves through advanced solutions and reliable supply chains. Looking ahead, competitive differentiation is likely to evolve, with an emphasis on delivering superior patient outcomes and leveraging technological advancements to meet the growing demands of the healthcare sector. ## Recent News & Developments The US Cardiopulmonary Exercise Testing Market has seen significant developments recently, particularly with advancements in technology and regulatory approvals. Companies such as GE Healthcare and Nihon Kohden are focusing on enhancing their product offerings to provide accurate diagnostics through innovative testing solutions. In terms of market dynamics, the increasing prevalence of cardiovascular diseases is driving demand for cardiopulmonary exercise testing, leading to a rise in market valuations for companies like CareFusion and Cosmed, which reported growth due in part to expanding applications in clinical settings.  Notably, in June 2023, CardioCommand acquired MediCardia, a strategic move aimed at enhancing capabilities in cardiopulmonary diagnostics. Additionally, partnerships among firms like Huntleigh and Cleveland Medical Devices are emerging to leverage synergies and improve patient care. Over the last two years, significant investments in Research and Development have been noted, with Borg Health and KORR Medical Technologies making strides in tailored exercise testing solutions. The US market’s landscape is evolving rapidly with an emphasis on integrating advanced technology and focusing on patient-centered approaches, thus reflecting a robust growth trajectory for the industry. ## Report Scope | MARKET SIZE 2024 | 235.2(USD Million) | | --- | --- | | MARKET SIZE 2025 | 254.91(USD Million) | | MARKET SIZE 2035 | 570.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.38% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Cardinal Health (US), Philips (NL), GE Healthcare (US), Schiller AG (CH), MediSoft (FR), Cosmed (IT), KORR Medical Technologies (US), Bodystat (GB) | | Segments Covered | Product Type, End User | | Key Market Opportunities | Integration of advanced wearable technology enhances patient monitoring in the cardiopulmonary exercise-testing market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the cardiopulmonary exercise-testing market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US cardiopulmonary exercise-testing market in 2024?** A: The market valuation was $235.2 Million in 2024. **Q: What is the projected market valuation for the US cardiopulmonary exercise-testing market by 2035?** A: The projected valuation for 2035 is $570.0 Million. **Q: What is the expected CAGR for the US cardiopulmonary exercise-testing market during the forecast period 2025 - 2035?** A: The expected CAGR is 8.38% during the forecast period 2025 - 2035. **Q: Which product types are included in the US cardiopulmonary exercise-testing market?** A: The product types include CPET metabolic carts and software. **Q: What were the valuations for CPET metabolic carts and software in 2024?** A: In 2024, CPET metabolic carts were valued at $150.0 Million, while software was valued at $85.2 Million. **Q: What are the key end-user segments in the US cardiopulmonary exercise-testing market?** A: Key end-user segments include Hospitals & Clinics, Diagnostic Centers, Ambulatory Centers, and Others. **Q: What were the market valuations for Hospitals & Clinics and Diagnostic Centers in 2024?** A: In 2024, Hospitals & Clinics were valued at $100.0 Million, and Diagnostic Centers were valued at $70.0 Million. **Q: Who are the key players in the US cardiopulmonary exercise-testing market?** A: Key players include Cardinal Health, Philips, GE Healthcare, Schiller AG, MediSoft, Cosmed, KORR Medical Technologies, and Bodystat. **Q: What is the projected growth trend for the US cardiopulmonary exercise-testing market?** A: The market is expected to grow significantly, reaching $570.0 Million by 2035. **Q: How do the valuations of Ambulatory Centers and Others compare in the US cardiopulmonary exercise-testing market?** A: In 2024, Ambulatory Centers were valued at $40.0 Million, while Others were valued at $25.2 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-cardiopulmonary-exercise-testing-market-53034*